×

Stock therapy: Hope for Celgene drug

5:40 PM ET Thu, 19 March 2015

Celgene's phase 2 study of its experimental Crohn's disease pill was published in The New England Journal of Medicine. Phase 3 is expected to start this year, reports CNBC's Meg Tirrell.